Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th

Rhea-AI Summary

Enovis (NYSE: ENOV) has announced it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2024 financial results on Wednesday, February 26th, 2025 at 8:30 a.m. Eastern Time. The company will release its earnings press release earlier that morning.

A presentation related to the call will be accessible from the 'Investors' section of Enovis' website. Investors can participate by dialing (833) 685-0901 for U.S. callers and (412) 317-5715 for International callers. A replay of the call will be available on the company's website later that day.

News Market Reaction – ENOV

-0.71%

1 alert

-0.71% News Effect

On the day this news was published, ENOV declined 0.71%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Wilmington, DE, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2024 financial results on Wednesday, February 26th, 2025 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call as well as a webcast can be accessed from the "Investors" section of Enovis' website at www.enovis.com.

Conference Call/Webcast Information

Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.

About Enovis

Enovis Corporation (NYSE: ENOV) is an innovation-driven, medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV.  For more information about Enovis, please visit www.enovis.com.

Availability of Information on the Enovis Website

Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares on ir.enovis.com.

Contact:

Kyle Rose
Vice President, Investor Relations
Enovis Corporation
investorrelations@enovis.com

FAQ

When will Enovis (ENOV) report Q4 and full year 2024 earnings?

Enovis will report its Q4 and full year 2024 earnings on Wednesday, February 26th, 2025, with the earnings release issued in the morning and a conference call at 8:30 a.m. Eastern Time.

How can investors access Enovis's (ENOV) Q4 2024 earnings call?

Investors can access the live webcast through Enovis's website or dial (833) 685-0901 for U.S. callers and (412) 317-5715 for International callers.

Will there be a replay available for Enovis's (ENOV) Q4 2024 earnings call?

Yes, a replay of the earnings call will be available on Enovis's website later on February 26th, 2025.

Where can investors find the presentation for Enovis's (ENOV) Q4 2024 earnings call?

The presentation related to the earnings call will be available in the 'Investors' section of Enovis's website at www.enovis.com.